Global healthcare company Abbott shared several strategies to help people with diabetes enjoy holiday feasts while keeping their sugar intake in check.  In a statementGlobal healthcare company Abbott shared several strategies to help people with diabetes enjoy holiday feasts while keeping their sugar intake in check.  In a statement

Abbott shares strategies for a diabetes-friendly holiday

Global healthcare company Abbott shared several strategies to help people with diabetes enjoy holiday feasts while keeping their sugar intake in check. 

In a statement on Tuesday, Abbott recommended simple measures such as controlling food portions and choosing healthier alternatives. 

“These everyday decisions allow people with diabetes to fully embrace the season, protect their health, and step into the new year with confidence and hope,” Dr. Gamaliel Tayao, Abbott’s head of medical affairs in the Philippines, said in the statement. 

Abbott suggested that, instead of white rice, brown rice can serve as a nutritious alternative, as it retains more essential vitamins, minerals, and antioxidants, while having a gentler effect on blood sugar levels. 

For other festive staples, the company recommended opting for grilled dishes over fried ones to reduce trans-fat intake, which is linked to heart disease and obesity. It also advised using leaner cuts, such as chicken breast or pork loin, for Filipino favorites like adobo and menudo to maintain flavor without excess fat. 

To further aid digestion and support healthy cholesterol levels, Abbott recommended boosting dishes like pancit and lumpia with fiber-rich vegetables such as carrots, squash, and bell peppers. 

For dessert, the company suggested prioritizing fresh fruits, which offer natural sweetness and fiber, over heavy, sugar-laden sweets. 

According to the International Diabetes Federation, the Philippines has 4.7 million adults with diabetes, representing 7.5% of the country’s nearly 72 million adult population. 

Beyond dietary changes, Abbott emphasized the importance of physical activity, noting that movement, like walking with loved ones or dancing, helps support glucose regulation. 

The company also highlighted the value of continuous glucose monitoring (CGM) devices for tracking real-time body responses, as well as the use of diabetes-specific nutritional drinks to prevent sugar spikes when schedules become busy. 

Abbott, a US-based global healthcare company, develops diagnostics, medical devices, nutrition products, and medicines. — Edg Adrian A. Eva

Market Opportunity
ConstitutionDAO Logo
ConstitutionDAO Price(PEOPLE)
$0,008455
$0,008455$0,008455
-4,67%
USD
ConstitutionDAO (PEOPLE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

China Blocks Nvidia’s RTX Pro 6000D as Local Chips Rise

China Blocks Nvidia’s RTX Pro 6000D as Local Chips Rise

The post China Blocks Nvidia’s RTX Pro 6000D as Local Chips Rise appeared on BitcoinEthereumNews.com. China Blocks Nvidia’s RTX Pro 6000D as Local Chips Rise China’s internet regulator has ordered the country’s biggest technology firms, including Alibaba and ByteDance, to stop purchasing Nvidia’s RTX Pro 6000D GPUs. According to the Financial Times, the move shuts down the last major channel for mass supplies of American chips to the Chinese market. Why Beijing Halted Nvidia Purchases Chinese companies had planned to buy tens of thousands of RTX Pro 6000D accelerators and had already begun testing them in servers. But regulators intervened, halting the purchases and signaling stricter controls than earlier measures placed on Nvidia’s H20 chip. Image: Nvidia An audit compared Huawei and Cambricon processors, along with chips developed by Alibaba and Baidu, against Nvidia’s export-approved products. Regulators concluded that Chinese chips had reached performance levels comparable to the restricted U.S. models. This assessment pushed authorities to advise firms to rely more heavily on domestic processors, further tightening Nvidia’s already limited position in China. China’s Drive Toward Tech Independence The decision highlights Beijing’s focus on import substitution — developing self-sufficient chip production to reduce reliance on U.S. supplies. “The signal is now clear: all attention is focused on building a domestic ecosystem,” said a representative of a leading Chinese tech company. Nvidia had unveiled the RTX Pro 6000D in July 2025 during CEO Jensen Huang’s visit to Beijing, in an attempt to keep a foothold in China after Washington restricted exports of its most advanced chips. But momentum is shifting. Industry sources told the Financial Times that Chinese manufacturers plan to triple AI chip production next year to meet growing demand. They believe “domestic supply will now be sufficient without Nvidia.” What It Means for the Future With Huawei, Cambricon, Alibaba, and Baidu stepping up, China is positioning itself for long-term technological independence. Nvidia, meanwhile, faces…
Share
BitcoinEthereumNews2025/09/18 01:37
Samsung To Unveil New AI-Connected Living Lineup at CES 2026

Samsung To Unveil New AI-Connected Living Lineup at CES 2026

Company introduces AI-powered appliances designed to deliver smarter living by enhancing fabric care, air conditioning and cleaning Highlighted models include upgraded
Share
AI Journal2025/12/18 09:16
XRP ETF Inflows Hit $8.54M as Institutional Exposure Rises to $1.16B

XRP ETF Inflows Hit $8.54M as Institutional Exposure Rises to $1.16B

XRP is currently trading at $1.86, consolidating near a key support zone while momentum remains weak. Institutional inflows into XRP-ETFs remain positive. Flow–
Share
Tronweekly2025/12/18 09:00